Semaglutide Titration Schedule

Starting semaglutide isn't as simple as jumping straight to the full dose. Your body needs time to adjust. That's why every provider follows a semaglutide titration schedule that gradually increases your dose over 16-20 weeks. This approach reduces side effects and gives your system time to adapt to the medication.

Key Takeaways: - The Standard Semaglutide Titration Schedule - Phase 1: Weeks 1-4 at 0.25 mg - Phase 2: Weeks 5-8 at 0.5 mg - Phase 3: Weeks 9-12 at 1.0 mg - Phases 4-5: Reaching the Therapeutic Dose (1.7 mg and 2.4 mg)

This guide walks you through each phase of the titration process. You'll learn what dose to expect, what side effects are common at each level, and practical tips for making each transition smoother.

The Standard Semaglutide Titration Schedule

The titration schedule for semaglutide follows a step-up pattern. You start at the lowest dose and increase every four weeks until you reach the target dose. Here is the standard schedule used for weight management:

Each dose increase happens at four-week intervals. This isn't arbitrary. Clinical trials established this timeline to balance effectiveness with tolerability. Rushing the schedule increases the risk of nausea and other GI side effects.

Your provider may modify this schedule. Some people need 6-8 weeks at a dose before moving up. Others may find their sweet spot at 1.0 mg or 1.7 mg and stay there. The right dose is the one that works for you with manageable side effects.

For a broader overview of how the medication works, check out our .

Phase 1: Weeks 1-4 at 0.25 mg

The first four weeks are all about introduction. The 0.25 mg dose isn't expected to produce significant weight loss. It exists to let your GI system get used to the medication. For a complete cost breakdown, see our semaglutide pricing comparison.

"The conversation about obesity needs to shift from willpower to biology. These medications work because obesity is a neuroendocrine disease, not a character flaw.") Dr. Fatima Cody Stanford, MD, MPH, Massachusetts General Hospital

What most people experience:

• Mild nausea, especially in the first 2-3 days after injection
• Slight decrease in appetite
• Possible fatigue or mild headache
• Little to no weight change (some people lose 1-3 pounds)

Tips for Phase 1:

• Choose an injection day that works with your schedule. Many people pick a day when they can rest the next morning in case of nausea.
• Start eating smaller meals now, even before appetite changes kick in. This builds the habit early.
• Stay hydrated. Aim for at least 64 ounces of water per day.
• Keep a log of how you feel each day. The makes this easy with daily check-ins and symptom tracking.

Don't get discouraged if nothing dramatic happens during this phase. The 0.25 mg dose is doing its job by preparing your body for the higher doses where the real results happen.

Free Download: Semaglutide Titration Tracker Print this week-by-week tracker to log your dose, weight, side effects, and notes through every phase of titration. Get yours free (we'll email it to you instantly. [Email Input] [Download Button]

Patient Perspective: "I was skeptical about another weight loss medication after trying so many things. By week 8 on semaglutide, I noticed I wasn't thinking about food constantly for the first time in years. The nausea was real the first two weeks, but manageable with smaller meals.") Sarah M., 47, FormBlends patient (name changed for privacy)

Phase 2: Weeks 5-8 at 0.5 mg

This is where most people start to notice real changes. Doubling the dose from 0.25 mg to 0.5 mg often brings a noticeable drop in appetite and the beginning of consistent weight loss.

What most people experience:

• Clearer appetite suppression. You may forget to eat or feel satisfied much sooner.
• Nausea may return for a few days after the dose increase, then settle.
• Weight loss of 1-2 pounds per week becomes common.
• Food preferences may shift. Many people lose interest in high-sugar and high-fat foods.

Tips for Phase 2:

• Prioritize protein at every meal. Aim for 25-30 grams per serving. This helps preserve muscle mass as you lose weight. Check out our for ideas.
• Don't skip meals. Even if you aren't hungry, eat small, nutrient-dense meals to keep energy up.
• If nausea hits after your dose increase, stick with bland foods for 24-48 hours. Crackers, rice, bananas, and broth work well.
• Start or continue a simple exercise routine. Even walking 20-30 minutes daily makes a difference.

This phase is a good checkpoint. If you're tolerating 0.5 mg well and seeing results, your provider may discuss whether to continue the standard schedule or hold at this dose a bit longer.

Phase 3: Weeks 9-12 at 1.0 mg

The 1.0 mg dose is where semaglutide really hits its stride for many people. Appetite suppression is strong. Weight loss becomes more consistent. You start to see meaningful changes.

What most people experience:

• Strong appetite reduction. Some people need reminders to eat.
• Steady weight loss, often 1.5-2 pounds per week.
• GI side effects from previous dose increases have usually settled by now.
• A brief return of nausea when stepping up, lasting 3-5 days.
• Improved energy and mood as weight drops.

Tips for Phase 3:

• If you're losing weight quickly, check in with your provider about nutrition. Rapid loss can mean you aren't getting enough calories or protein.
• Consider adding resistance training if you haven't already. Preserving lean muscle mass becomes increasingly important.
• Watch for constipation. Slower gastric emptying at higher doses can cause this. Fiber, water, and movement help.
• Continue tracking in the . Your provider can review your data at your next check-in.

Some people find that 1.0 mg is their ideal maintenance dose. If your weight loss is on track and side effects are minimal, your provider may decide to stay here rather than push higher. This is a medical decision based on your individual response.

Phases 4-5: Reaching the Therapeutic Dose (1.7 mg and 2.4 mg)

The final two phases bring you to the full therapeutic dose studied in clinical trials.

Phase 4: Weeks 13-16 at 1.7 mg

By this point your body has adapted to semaglutide over three months. The jump to 1.7 mg is usually well tolerated. Appetite suppression may intensify slightly. Weight loss continues at a steady pace.

Watch for these signals that the dose may be too aggressive:

• Persistent nausea lasting more than a week after the increase
• Vomiting more than once after meals
• Inability to eat enough to meet basic nutritional needs
• Severe fatigue

If any of these happen, contact your provider. They may extend Phase 3 before trying 1.7 mg again.

Phase 5: Week 17+ at 2.4 mg

This is the full dose used in the major weight loss clinical trials. At 2.4 mg weekly, you're at the dosage that produced an average of 14.9% body weight^[1] loss in the STEP 1^[1] (Wilding et al., NEJM, 2021) trial.

Not everyone reaches or needs 2.4 mg. Your provider will assess whether the full dose is right for you based on your progress, side effects, and goals.

At the therapeutic dose, you should be in a steady routine. Weekly injections. Regular meals focused on protein and whole foods. Consistent exercise. Ongoing check-ins with your provider. This is the long game, and the medication works best when it's part of a complete plan.

Frequently Asked Questions

What if I can't tolerate a dose increase?

Talk to your provider. They may extend your time at the current dose by 2-4 additional weeks before trying the increase again. Some people do well with a slower titration schedule. Your provider can also suggest strategies to manage specific side effects.

Can I go back to a lower dose if I feel sick?

Yes, but only with your provider's guidance. If a dose increase causes significant side effects, your provider may temporarily reduce your dose and try the increase again later. Don't adjust your dose on your own.

How do I know when I have reached the right dose?

The right dose is different for everyone. Signs you're at your ideal dose include steady weight loss of 1-2 pounds per week, manageable or no side effects, reduced appetite without feeling unable to eat, and overall improved well-being. Your provider will help determine this during follow-up visits.

Does the titration schedule change for compounded semaglutide?

The titration principles are the same. Start low, go slow. Compounded semaglutide prepared by a licensed 503A pharmacy contains compounded formulations of the active ingredient. Your provider will prescribe the appropriate titration schedule for your specific formulation.

What happens if I miss a dose during titration?

If fewer than 5 days have passed since your missed dose, take it as soon as you remember. If more than 5 days have passed, skip it and take your next dose on your regular day. Missing doses during titration can slow your progress, so set a weekly reminder to stay on track.

Start your weight loss Today

Every transformation starts with a single step. Talk to a licensed FormBlends provider about whether this approach is right for you, consultations are free and confidential.

Sources &. References

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
2. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
3. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
4. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
5. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
6. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
7. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
8. Nauck MA, Meier JJ. Management of endocrine disease: Are all GLP-1 agonists equal in the treatment of type 2 diabetes? Eur J Endocrinol. 2019;181(6):R211-R234. Doi:10.1530/EJE-19-0566
9. Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files. NCHS Data Brief. No. 492. CDC/NCHS. 2023.
10. Sumithran P, Prendergast LA, Delbridge E, et al. Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med. 2011;365(17):1597-1604. Doi:10.1056/NEJMoa1105816

This content is provided for informational and educational purposes only. It isn't a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed healthcare provider with any questions about a medical condition or treatment plan.

Last updated: 2026-03-24